Bioventus(BVS)
$11.18+0.16 (+5.37%)
BVS
Bioventus financials statements
$11.18
At close:+0.16 (+5.37%)
Want to see BVS full AI Analyst Report?
Bioventus (BVS) Ratios
230 Followers
Bioventus Ratios
BVS's free cash flow for Q3 2026 was $20.32M. For the 2026 fiscal year, BVS's free cash flow was decreased by $-334.00K and operating cash flow was $20.66M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.70 | 1.31 | 1.53 | 0.90 | 1.45 |
| Quick Ratio | 1.19 | 0.87 | 1.01 | 0.62 | 1.11 |
| Cash Ratio | 0.32 | 0.20 | 0.21 | 0.10 | 0.24 |
| Solvency Ratio | 0.15 | 0.03 | -0.17 | -0.11 | 0.08 |
| Operating Cash Flow Ratio | 0.46 | 0.18 | 0.09 | -0.04 | 0.13 |
| Short-Term Operating Cash Flow Coverage | 3.85 | 1.42 | 0.55 | -0.41 | 1.27 |
| Net Current Asset Value | $ -182.27M | $ -266.74M | $ -321.79M | $ -687.85M | $ -428.97M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.46 | 0.46 | 0.49 | 0.30 | 0.29 |
| Debt-to-Equity Ratio | 1.69 | 2.27 | 2.27 | 1.29 | 0.78 |
| Debt-to-Capital Ratio | 0.63 | 0.69 | 0.69 | 0.56 | 0.44 |
| Long-Term Debt-to-Capital Ratio | 0.60 | 0.68 | 0.68 | 0.54 | 0.43 |
| Financial Leverage Ratio | 3.71 | 4.92 | 4.67 | 4.22 | 2.67 |
| Debt Service Coverage Ratio | 2.21 | 0.67 | -0.34 | -1.71 | 2.48 |
| Interest Coverage Ratio | 2.21 | -0.31 | -2.01 | -13.91 | 10.85 |
| Debt to Market Cap | 0.60 | 0.49 | 1.20 | 2.61 | 0.54 |
| Interest Debt Per Share | 5.07 | 5.73 | 6.95 | 7.01 | 7.89 |
| Net Debt to EBITDA | 2.62 | 7.50 | -15.51 | -3.19 | 6.90 |
| Profitability Margins | |||||
| Gross Profit Margin | 67.32% | 67.72% | 64.06% | 64.65% | 70.25% |
| EBIT Margin | 9.19% | -1.80% | -15.70% | -34.56% | 2.46% |
| EBITDA Margin | 17.46% | 6.84% | -4.50% | -23.75% | 10.55% |
| Operating Profit Margin | 10.31% | -2.09% | -15.95% | -32.66% | 2.80% |
| Pretax Profit Margin | 4.53% | -8.57% | -23.64% | -36.91% | 2.20% |
| Net Profit Margin | 4.00% | -5.85% | -30.49% | -30.99% | 4.50% |
| Continuous Operations Profit Margin | 4.80% | -7.65% | -23.66% | -28.25% | 2.66% |
| Net Income Per EBT | 88.42% | 68.28% | 129.00% | 83.96% | 204.21% |
| EBT Per EBIT | 43.91% | 410.10% | 148.19% | 113.03% | 78.67% |
| Return on Assets (ROA) | 3.33% | -4.61% | -19.27% | -11.56% | 1.58% |
| Return on Equity (ROE) | 12.35% | -22.67% | -90.00% | -48.80% | 4.22% |
| Return on Capital Employed (ROCE) | 11.19% | -2.31% | -12.86% | -15.65% | 1.15% |
| Return on Invested Capital (ROIC) | 10.79% | -1.96% | -12.32% | -11.62% | 1.13% |
| Return on Tangible Assets | 7.39% | -10.62% | -48.65% | -21.88% | 5.06% |
| Earnings Yield | 4.59% | -4.89% | -47.32% | -99.05% | 2.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.43 | 4.50 | 4.17 | 3.76 | 3.45 |
| Payables Turnover | 16.99 | 7.81 | 7.99 | 4.93 | 7.58 |
| Inventory Turnover | 2.26 | 2.00 | 2.02 | 2.14 | 2.08 |
| Fixed Asset Turnover | 21.02 | 17.10 | 10.26 | 11.60 | 10.73 |
| Asset Turnover | 0.83 | 0.79 | 0.63 | 0.37 | 0.35 |
| Working Capital Turnover Ratio | 6.39 | 7.27 | 16.78 | 20.16 | 5.03 |
| Cash Conversion Cycle | 222.63 | 216.78 | 222.84 | 194.06 | 233.33 |
| Days of Sales Outstanding | 82.44 | 81.11 | 87.48 | 97.14 | 105.85 |
| Days of Inventory Outstanding | 161.68 | 182.40 | 181.03 | 170.90 | 175.64 |
| Days of Payables Outstanding | 21.48 | 46.73 | 45.66 | 73.99 | 48.16 |
| Operating Cycle | 244.11 | 263.51 | 268.50 | 268.04 | 281.50 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.11 | 0.59 | 0.24 | -0.22 | 0.51 |
| Free Cash Flow Per Share | 1.07 | 0.58 | 0.13 | -0.24 | 0.05 |
| Dividend Paid and CapEx Coverage Ratio | 28.87 | 38.56 | 2.08 | -9.16 | 1.08 |
| Capital Expenditure Coverage Ratio | 28.87 | 38.56 | 2.08 | -9.16 | 1.10 |
| Operating Cash Flow Coverage Ratio | 0.24 | 0.12 | 0.04 | -0.03 | 0.06 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.07 | 0.03 | -0.03 | 0.05 |
| Free Cash Flow Yield | 14.41% | 5.51% | 2.42% | -9.37% | 0.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 21.88 | -20.19 | -2.11 | -1.01 | 34.01 |
| Price-to-Sales (P/S) Ratio | 0.87 | 1.20 | 0.64 | 0.31 | 1.53 |
| Price-to-Book (P/B) Ratio | 2.69 | 4.64 | 1.90 | 0.49 | 1.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.94 | 18.16 | 41.36 | -10.67 | 313.61 |
| Price-to-Operating Cash Flow Ratio | 6.70 | 17.69 | 21.52 | -11.84 | 28.66 |
| Price-to-Earnings Growth (PEG) Ratio | -0.13 | 0.26 | 0.55 | -0.00 | -0.25 |
| Enterprise Value Multiple | 7.62 | 24.99 | -29.82 | -4.51 | 21.39 |
| Enterprise Value | 755.78M | 980.27M | 688.03M | 548.11M | 972.65M |
| EV to EBITDA | 7.62 | 24.99 | -29.82 | -4.51 | 21.39 |
| EV to Sales | 1.33 | 1.71 | 1.34 | 1.07 | 2.26 |
| EV to Free Cash Flow | 10.58 | 25.94 | 86.20 | -36.50 | 462.94 |
| EV to Operating Cash Flow | 10.22 | 25.27 | 44.84 | -40.49 | 42.31 |
| Tangible Book Value Per Share | -2.21 | -3.47 | -4.29 | -3.83 | -6.80 |
| Shareholders’ Equity Per Share | 2.76 | 2.26 | 2.77 | 5.30 | 10.09 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.06 | 0.11 | -0.00 | 0.23 | -0.21 |
| Revenue Per Share | 8.53 | 8.77 | 8.18 | 8.34 | 9.48 |
| Net Income Per Share | 0.34 | -0.51 | -2.49 | -2.59 | 0.43 |
| Tax Burden | 0.88 | 0.68 | 1.29 | 0.84 | 2.04 |
| Interest Burden | 0.49 | 4.75 | 1.51 | 1.07 | 0.90 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.03 | 0.05 | 0.04 |
| SG&A to Revenue | 0.55 | 0.57 | 0.59 | 0.64 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.01 | 0.03 | 0.05 |
| Income Quality | 2.71 | -122.00 | -0.13 | 0.09 | 2.01 |
Currency in USD
